Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUS

PURPOSE: The role of obesity in glioblastoma remains unclear, as previous analyses have reported contradicting results. Here, we evaluate the prognostic impact of obesity in two trial populations; CeTeG/NOA-09 (n = 129) for MGMT methylated glioblastoma patients comparing temozolomide (TMZ) to lomust...

Descripción completa

Detalles Bibliográficos
Autores principales: Weller, Johannes, Schäfer, Niklas, Schaub, Christina, Potthoff, Anna-Laura, Steinbach, Joachim P., Schlegel, Uwe, Sabel, Michael, Hau, Peter, Seidel, Clemens, Krex, Dietmar, Goldbrunner, Roland, Pietsch, Torsten, Tzaridis, Theophilos, Zeyen, Thomas, Borger, Valeri, Güresir, Erdem, Vatter, Hartmut, Herrlinger, Ulrich, Schneider, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325931/
https://www.ncbi.nlm.nih.gov/pubmed/35704157
http://dx.doi.org/10.1007/s11060-022-04046-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325931/
https://www.ncbi.nlm.nih.gov/pubmed/35704157
http://dx.doi.org/10.1007/s11060-022-04046-z

Ejemplares similares